dcsimg

ag真人平台官方

Application Proof
 
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
YOU SHOULD READ THE WARNING IN THE DOCUMENT.
 
► Warning
► ag真人平台官方:Important
► ag真人平台官方:Expected Timetable
► Contents
► Summary
► ag真人平台官方:Definitions
► Glossary of Technical Terms
► ag真人平台官方:Forward-looking Statements
► ag真人平台官方:Risk Factors
► Waivers and Consents from Strict Compliance with the Hong Kong Listing Rules
► Information about this Document and the [REDACTED]
► Directors, Supervisors and Parties Involved in the [REDACTED]
► ag真人平台官方:Corporate Information
► ag真人平台官方:Industry Overview
► ag真人平台官方:Regulatory Environment
► ag真人平台官方:History, Development and Corporate Structure
► Business
► ag真人平台官方:Relationship with the Controlling Shareholders
► ag真人平台官方:Connected Transaction
► ag真人平台官方:Directors, Supervisors and Senior Management
► ag真人平台官方:Share Capital
► ag真人平台官方:Substantial Shareholders
► ag真人平台官方:Financial Information
► ag真人平台官方:Future Plans and Use of [REDACTED]
► ag真人平台官方:[REDACTED]
► ag真人平台官方:Structure of the [REDACTED]
► ag真人平台官方:How to Apply for the [REDACTED]
► ag真人平台官方:Appendix I - Accountants' Report
► ag真人平台官方:Appendix II - [REDACTED]
► ag真人平台官方:Appendix III - Taxation and Foreign Exchange
► Appendix IV - Summary of Principal Legal and Regulatory Provisions
► ag真人平台官方:Appendix V - Summary of Articles of Association
► ag真人平台官方:Appendix VI - Statutory and General Information
► Appendix VII - Documents Delivered to the Registrar of Companies in Hong Kong and Available for Inspection